A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

Clinical trial NCT06342700 · COMPLETED

Trial details

NCT number: NCT06342700
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Disorder Healthy Volunteers

Start date: 2024-03-25
Primary completion: 2024-04-23
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.